Bio-Rad Laboratories (BIO)

Bio-Rad Laboratories (BIO) Income Statement


Bio-Rad Laboratories Income Statement

Last quarter (Q1 2024), Bio-Rad Laboratories's total revenue was $610.82M, a decrease of -9.75% from the same quarter last year. In Q1, Bio-Rad Laboratories's net income was $383.92M. See Bio-Rad Laboratories’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.61B$ 2.67B$ 2.80B$ 2.92B$ 2.55B$ 2.31B
Cost of Revenue
$ 1.21B$ 1.24B$ 1.23B$ 1.28B$ 1.11B$ 1.05B
Gross Profit
$ 1.39B$ 1.43B$ 1.57B$ 1.64B$ 1.44B$ 1.26B
Operating Expense
$ 1.07B$ 1.09B$ 1.08B$ 1.14B$ 1.03B$ 1.03B
Operating Income
$ 320.59M$ 337.80M$ -2.32B$ -2.42B$ 410.96M$ 229.66M
Net Non Operating Interest Income Expense
$ -49.38M$ -49.44M$ -38.11M$ -1.55M$ -3.66M$ 7.08M
Other Income Expense
$ 722.08M$ 1.15B$ 2.35B$ -7.88B$ 4.50B$ 2.02B
Pretax Income
$ -443.83M$ -850.10M$ -4.70B$ 5.45B$ 4.91B$ 2.26B
Tax Provision
$ -121.48M$ -212.78M$ -1.08B$ 1.19B$ 1.10B$ 502.41M
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -322.37M$ -637.32M$ -3.63B$ 4.25B$ 3.81B$ 1.76B
Basic EPS
$ -10.33$ -21.82$ -121.79$ 142.61$ 127.86$ 58.93
Diluted EPS
$ -10.23$ -21.82$ -121.79$ 140.83$ 126.20$ 58.27
Basic Average Shares
$ 115.76M$ 29.21M$ 29.79M$ 29.83M$ 29.77M$ 29.84M
Diluted Average Shares
$ 115.63M$ 29.21M$ 29.79M$ 30.21M$ 30.16M$ 30.18M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
----$ 10.52$ 7.06
Rent Expense Supplemental
Total Expenses
$ 2.28B$ 2.33B$ 2.32B$ 2.42B$ 2.13B$ 2.08B
Net Income From Continuing And Discontinued Operation
$ -322.37M$ -637.32M$ -3.63B$ 4.25B$ 3.81B$ 1.76B
Normalized Income
$ -1.38B$ -1.05B--$ 312.60M$ 183.66M
Interest Expense
----$ 21.86M$ 23.42M
$ -394.48M$ -800.66M$ -4.67B$ 5.45B$ 4.93B$ 2.28B
$ -320.18M$ -654.76M$ -4.71B$ 5.45B$ 5.07B$ 2.42B
Currency in USD

Bio-Rad Laboratories Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis